Time: 4 hours ? The launch of iLite? Assay Ready Cells targeting anti-CD20 antibody development, brings the first four products from EuroDiagnostica's ADCC product line to market and showcases the unique set-up of the iLite system. The iLite ADCC anti-CD20 assay has got a turnaround time of less than 5 hours and has got sensitivity in the pg/mL area, and includes many of the other iLite features, such as normalization, serum tolerance and low lot-to-lot variation. Measuring the ability of a drug to induce antibody-dependent cell-mediated cytotoxicity (ADCC) in a straight forward, sensitive and reproducible manner, is a key aspect in development and manufacturing of antibody-based therapeutics. The iLite ADCC Activity Assay, unique in its set-up, includes ADCC Effector Assay Ready Cells and matched Target Assay Ready Cells, engineered to work optimally together and give unparalleled sensitivity. A negative control cell line is also available for each target, allowing screening for unspecific activation of ADCC, giving added value to each experiment.